Jimmy Wyman is running the Boston Marathon for his wife, who has a rare form of lung cancer, in support of Dana-Farber.

Lung cancer is the number one cancer killer in the world. Biomarker testing improves outcomes in stage IV non-small cell lung cancer (NSCLC), however its ...

The FDA cleared the firm this week to begin a Phase I study of ALX2004 in EGFR-expressing solid tumors, which could start in a few months.

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Biomarker testing in advanced NSCLC has increased in recent years, but turnaround time has remained roughly the same, data suggest.

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Baptist Health-Fort Smith introduces the ion robot to enhance early lung cancer detection in the River Valley.